STAT+: Skin patch for toddlers with peanut allergy shows promising results in late-stage trial
If the FDA eventually approves the skin patch, it would become the first treatment option available to toddlers with peanut allergies.
Parents of kids who have peanut allergies have to practice constant vigilance, whether that means carefully skimming the ingredients on food packaging or warning teachers about the dangers of unexpected treats at school. A new study in the New England Journal of Medicine presents a simple treatment option for peanut allergies in kids from 1 to 3 years of age: a skin patch.
In the study, published Wednesday, French pharmaceutical company DBV Technologies and a group of investigators from across the U.S., Europe, Australia, and Canada discuss the results of a Phase 3 trial of the Viaskin Peanut skin patch. In the double-blind, randomized, placebo-controlled trial, two-thirds of toddlers with peanut allergies responded to treatment and were able to tolerate ingesting the equivalent of a few peanuts, compared to one-third of toddlers in the placebo arm.
What's Your Reaction?
